皮肤生物学分子革命:全基因组关联研究与统计大数据计算时代
本文综述了全基因组关联研究(GWAS)在皮肤生物学中的应用。微阵列技术可在同种群数千个体中检测数千常见遗传标记(SNP),已发现斑秃、白癜风、银屑病和特应性皮炎等疾病的常见变异,揭示生物学通路并提示新药靶点。GWAS数据分析需考虑多重检验、群体分层和重复验证等统计问题,同时存在缺失遗传度问题;下一代测序将揭示更多变异但数据量更大、挑战更多。
要点
- GWAS已鉴定斑秃、白癜风、银屑病和特应性皮炎等疾病的常见变异,提示生物学通路与药物靶点。
- GWAS数据分析需处理多重标记检验、群体分层和重复验证等统计问题。
- 当前GWAS方法无法完全解释疾病缺失遗传度,下一代测序可补充发现新变异。
核心结论
- 皮肤生物学研究已进入大数据时代,需要重型计算工具和新型统计方法。
- GWAS已发现多种皮肤病相关的常见变异,为理解生物学通路和发现药物靶点提供线索。
- GWAS存在缺失遗传度问题,下一代测序有望揭示更多疾病易感变异但面临更大数据挑战。
研究设计与样本
- 综述性文章,讨论GWAS在皮肤疾病中的应用、统计方法学问题及下一代测序技术前景。
- 微阵列技术可在同种群数千个体中检测数千常见遗传标记(SNP)。
- 下一代测序技术可对相似患者队列进行外显子组和基因组测序。
主要发现
- 斑秃、白癜风、银屑病和特应性皮炎中已发现与疾病相关的常见变异。
- 痤疮、肤色和皮肤癌等其他皮肤表型也正在通过GWAS进行研究。
- GWAS数据分析需考虑多重标记检验、群体分层和重复验证等统计问题。
- 当前GWAS方法无法完全解释疾病缺失遗传度。
- 下一代测序生成的数据量比微阵列大数个数量级,鉴定致病变异面临相应挑战。
临床怎么用
- 皮肤科医生可关注GWAS发现的疾病相关变异,理解其揭示的生物学通路和潜在药物靶点。
- 解读GWAS结果时需注意多重检验、群体分层和重复验证等统计要求。
- 认识GWAS的缺失遗传度局限,下一代测序有望补充发现新变异。
局限性
- 当前GWAS方法无法完全解释疾病的缺失遗传度。
- 下一代测序数据量比微阵列大数个数量级,鉴定致病变异面临挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The investigation of biological systems involving all organs of the body including the skin is in era of big data. This requires heavy-duty computational tools, and novel statistical methods. Microarrays have allowed the interrogation of thousands of common genetic markers in thousands of individuals from the same population (termed genome wide association studies or GWAS) to reveal common variation associated with disease or phenotype. These markers are usually single nucleotide polymorphisms (SNPs) that are relatively common in the population. In the case of dermatological diseases such as alopecia areata, vitiligo, psoriasis and atopic dermatitis, common variants have been identified that are associated with disease, and these provide insights into biological pathways and reveal possible novel drug targets. Other skin phenotypes such as acne, color and skin cancers are also being investigated with GWAS. Analyses of such large GWAS datasets require a consideration of a number of statistical issues including the testing of multiple markers, population substructure, and ultimately a requirement for replication. There are also issues regarding the missing heritability of disease that cannot be entirely explained with current GWAS approaches. Next generation sequencing technologies such as exome and genome sequencing of similar patient cohorts will reveal additional variants contributing to disease susceptibility. However, the data generated with these approaches will be orders of magnitude greater than that those generated with arrays, with concomitant challenges in the identification of disease causing variants.
引用
- Anbunathan H, Bowcock AM. The Molecular Revolution in Cutaneous Biology: The Era of Genome-Wide Association Studies and Statistical, Big Data, and Computational Topics. J Invest Dermatol. 2017. PMID: 28411841. doi:10.1016/j.jid.2016.03.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。